SCHEMBL4841319

SCHEMBL4841319

COC(=O)Cc1ccc(OCCN)cc1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 1/20 0.41
MTNR1B P49286 1/20 0.41
KDM4E B2RXH2 3/20 0.41
HPGD P15428 3/20 0.41
ALDH1A1 P00352 2/20 0.41
TSHR P16473 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PLAU P00749 1/20 0.40
CARM1 Q86X55 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
PDIA6 Q15084 1/20 0.39
PPARG P37231 1/20 0.39
PPARD Q03181 1/20 0.39
PPARA Q07869 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
DYRK1A Q13627 1/20 0.39
SUCNR1 Q9BXA5 1/20 0.39
KDM1A O60341 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4845633 0.86 KDM1A (0.49) MTNR1AMTNR1BKDM4EHPGDALDH1A1
SCHEMBL3918324 0.82 ALDH1A1 (0.54) KDM4EHPGDALDH1A1RAB9AHSD17B10
SCHEMBL10927781 0.78 S1PR1 (0.57) ALDH1A1RAB9ASMN1; SMN2PPARA
SCHEMBL9909832 0.78 CARM1 (0.39) PLAUCARM1PDIA6
SCHEMBL926955 0.77 ALDH1A1 (0.54) KDM4EALDH1A1RAB9ASMN1; SMN2
SCHEMBL4844663 0.76 ALDH1A1 (0.46) KDM4EHPGDALDH1A1TSHRRAB9A
SCHEMBL30940160 0.75 ALDH1A1 (0.45) KDM4EHPGDALDH1A1TSHRRAB9A
SCHEMBL1408363 0.75 ALDH1A1 (0.45) KDM4EHPGDALDH1A1TSHRRAB9A
SCHEMBL13932764 0.75 ALDH1A1 (0.38) MTNR1AMTNR1BKDM4EHPGDALDH1A1
SCHEMBL10015983 0.75 NPC1 (0.45) KDM4EHPGDALDH1A1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102746214-A Novel indoline compounds FOURNIER LAB SA 2012-10-24 CN disclosed
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed
CN-101184731-A Indoline compounds FOURNIER LAB SA (FR) 2008-05-21 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 MTNR1A 47/4885MTNR1B 82/4885KDM4E 1574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.